WaferGen Biosystems, Inc. (OTC BB: WGBS)

WaferGen Biosystems, Inc. (OTC BB: WGBS) is focused on developing, manufacturing and commercializing next-generation systems for gene expression, genotyping, stem cell research and cell biology for the life science and pharmaceutical industries. The company is developing what could become the platform of choice for genetic analysis as well as cell monitoring enabling genomics and cell biology from research to clinic. WaferGen’s innovative systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies. For further information, visit the Company’s web site at www.wafergen.com.